# 119-s-3134: Combating Counterfeit Pharmaceuticals Act of 2025

119-s-3134, Combating Counterfeit Pharmaceuticals Act of 2025, is a 119th Congress bill sponsored by Sen. Cotton, Tom [R-AR] (R-AR); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-s-3134
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-s-3134
- Congress: 119
- Title: Combating Counterfeit Pharmaceuticals Act of 2025
- Status: introduced
- Introduced: 2025-11-06
- Sponsor: Sen. Cotton, Tom [R-AR] (R-AR)
- Cosponsors: 1
- Policy area: International Affairs
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Broadens sanctions to cover counterfeit drugs and copy‑cat ingredients.** It would expand the Fentanyl Sanctions Act into a wider tool against illicit drugs, add a patient waiver for prescription shortages, and give the Director of National Intelligence more flexibility to use intelligence against traffickers. - Patients and families: Would create a waiver process so people can access prescription medicines that are on the drug shortage list maintained by the Secretary of Health and Human Services under section 506E of the Food, Drug, and Cosmetic Act. - Intelligence and enforcement agencies: Would let the Director of National Intelligence delegate identification of foreign drug traffickers and reconfigure the intelligence program on the use of intelligence resources to give more operational flexibility in illicit drug efforts. - Traffickers, counterfeiters, and regulators: Expands definitions and replaces references to "opioids" with "illicit drugs," explicitly covering counterfeit drugs and defined "copy‑cat ingredients," and makes technical and reporting changes across the statute.

## Cosponsors (1)

- Sen. Ricketts, Pete [R-NE] (R-NE), 2025-11-06T00:00:00.000Z

## Provisions PRIA read

- Waivers for drugs on shortage list: benefit, medium. If enacted, the bill would let agencies grant waivers to allow access to prescription medicines on the HHS drug shortage list. If your medicine is on that list, this could help you get it during an active shortage. The change would take effect upon enactment.
- Broader enforcement against illicit drugs: benefit, medium. If enacted, the bill would broaden the Fentanyl Sanctions Act to cover “illicit drugs,” not just opioids. It would rename and reconfigure the intelligence‑use provisions and let the Director of National Intelligence use a designee for certain identification and briefing duties. These changes would…
- Stronger rules on counterfeit drugs: benefit, medium. If enacted, the bill would add “counterfeit drugs” and “copy‑cat ingredients” to the sanctions law. It would define copy‑cat ingredients as substances meant to mimic approved prescription drug ingredients or made by a different process or at lower purity. Agencies would have clearer authority to bl…

## Related bills

- 119-s-2342: Intelligence Authorization Act for Fiscal Year 2026
- 119-s-4615: Intelligence Authorization Act for Fiscal Year 2027
- 119-s-1748: Kids Online Safety Act
- 119-s-292: Educational Choice for Children Act of 2025
- 119-s-2904: SHADOW Fleet Sanctions Act of 2026
- 119-s-541: ELITE Vehicles Act

## Sources
- [119-s-3134 on Congress.gov](https://www.congress.gov/bill/119th-congress/senate-bill/3134)

## Related
- [119-s-2342: Intelligence Authorization Act for Fiscal Year 2026](https://policyrisk.com/legislation/119-s-2342)
- [119-s-4615: Intelligence Authorization Act for Fiscal Year 2027](https://policyrisk.com/legislation/119-s-4615)
- [119-s-1748: Kids Online Safety Act](https://policyrisk.com/legislation/119-s-1748)
- [119-s-292: Educational Choice for Children Act of 2025](https://policyrisk.com/legislation/119-s-292)
- [119-s-2904: SHADOW Fleet Sanctions Act of 2026](https://policyrisk.com/legislation/119-s-2904)
- [119-s-541: ELITE Vehicles Act](https://policyrisk.com/legislation/119-s-541)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-s-3134 (as of 2026-04-21).